U.S. move to ease patents on COVID-19 vaccines sparks passionate reaction

Activists cheered, pharmaceutical companies complained and government leaders assessed next steps after the Biden administration's blockbuster move to support an easing of patent and other protections on COVID-19 vaccines that many hope will help poorer countries get more doses and speed the end of the pandemic.